press releases
press releases
SMURF-Therapeutics, Inc.
PRESS RELEASES
Dr. Emile Youssef appointed Chief Medical Officer at SMURF-Therapeutics, Inc.
Jan292024
Time: 12:00 am
SMURF-Therapeutics, Inc. Announces Six New Appointments to Scientific Advisory Board
Dec12023
Time: 12:00 am - 12:00 am
EVENTS & PRESENTATIONS
Novel cancer treatment paradigm targeting hypoxia-induced factor in conjunction with current therapies to overcome resistance.
Jul182023
Time: 12:00 am - 12:00 am
IN THE NEWS
SMURF2 predisposes cancer cell toward ferroptosis in GPX4-independent manners by promoting GSTP1 degradation: Molecular Cell
Dec72023
Time: 12:00 am - 12:00 am